Key Takeaways
- JPMorgan (JPM) recently raised its price target for Emerson Electric (EMR) to $151 from $135, an increase of 11.85%, on October 15, 2025, maintaining a Neutral rating.
- For J Sainsbury Plc (SBRY), JPMorgan (JPM) increased its price target to 363p from 330p on September 15, 2025, reiterating an Overweight rating.
- These adjustments by JPMorgan contradict recent unverified headlines suggesting price target trims for both companies.
JPMorgan's recent analyst actions on Emerson Electric (EMR) and J Sainsbury Plc (SBRY) reveal upward revisions to their price targets, a move that stands in contrast to uncorroborated reports circulating on November 10, 2025, which indicated reductions. The investment bank's latest assessments, based on verifiable market information, reflect a more optimistic outlook for both companies.
For industrial automation giant Emerson Electric (EMR), JPMorgan (JPM) raised its price target to $151 from $135 on October 15, 2025. This significant increase of 11.85% was accompanied by the maintenance of a Neutral rating on the shares. The adjustment came as part of a Q3 earnings preview for the electrical equipment and multi-industry sector, with JPMorgan expressing a "bit more cautious" near-term view on the group but noting that the valuation setup "is now at least more attractive".
Similarly, British supermarket chain J Sainsbury Plc (SBRY) also saw a positive adjustment from JPMorgan (JPM). On September 15, 2025, the firm increased its price target for Sainsbury to 363p from 330p, while reiterating an Overweight rating. This upward revision was made ahead of the company's first-half 2026 earnings report, with JPMorgan placing the stock on a "Positive Catalyst Watch" due to "solid execution". Analysts also upgraded their first-half EBIT estimates by approximately 6.5% and fiscal year 2026 estimates by around 5.5%, positioning their forecast about 10% above both company guidance and consensus for retail adjusted operating profit.
These confirmed analyst actions highlight JPMorgan's more favorable stance on both Emerson (EMR) and Sainsbury (SBRY), emphasizing growth potential and solid operational performance rather than any recent downgrades or trims. Investors should note these verified reports when evaluating the companies' market positions.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.